iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through pre-clinical and clinical development.
Imprint: https://iomx.com/imprint
Location: Germany, Bavaria, Martinsried
Member count: 11-50
Total raised: $148.923812M
Founded date: 2016
Investors 2
| Date | Name | Website |
| 26.12.2021 | MIG AG | mig.ag |
| 08.11.2022 | M Ventures | m-ventures... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 11.12.2021 | Series B | $73.560533... | - | m-ventures... |
| 05.10.2021 | Series B | $75.363279... | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 11.12.2021 | iOmx Thera... | Martinsried / Munich, Germany,... | - | - | m-ventures... |
| 09.10.2021 | Top 10 Hea... | The global healthcare market i... | - | - | vcbay.news... |
| 06.10.2021 | iOmx raise... | Martinsried-based iOmx Therape... | - | - | bio-m.org/... |
| 05.10.2021 | iOmx Thera... | iOmx Therapeutics AG, a Martin... | Germany | - | finsmes.co... |
| 30.09.2019 | iOmx Thera... | iOmx Therapeutics announced to... | - | - | wellington... |